Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: A single-center, randomized trial

Internal Medicine

Volumn 53, Issue 20, 2014, Pages 2265-2272

  Luo, Yu ^a   Wang, Xiaodong ^a   Ye, Zi ^a   Lai, Yan ^a   Yao, Yian ^a   Li, Jimin ^a   Liu, Xuebo ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Contrast induced nephropathy; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; IOPAMIDOL; CONTRAST MEDIUM; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOPLASTY; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD TRANSFUSION; CARDIOGENIC SHOCK; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; INTRAAORTIC BALLOON PUMP; LOADING DRUG DOSE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REMEDIAL HYDRATION; RENAL REPLACEMENT THERAPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; CHEMICALLY INDUCED; COMPLICATION; ELECTROCARDIOGRAPHY; FLUID THERAPY; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CREATININE; ELECTROCARDIOGRAPHY; FEMALE; FLUID THERAPY; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84907994312     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1853     Document Type: Article

References (30)

1. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 21: 74-85, 2008.
2. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 51: 1419-1428, 2008.
3. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341: 1413-1419, 1999.
4. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intra-venous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361: 13-20, 2003.
5. Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44: 1780-1785, 2004.
6. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Roentgenol 136: 859-861, 1981.
7. Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105: 624- 628, 2010.
8. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150: 170-177, 2009.
9. Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98: 59-77, 2006.
10. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Dietin Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999.
11. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 405: 5-37, 1968.
12. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase clinical findings through hospital discharge. Circulation 76: 142-154, 1987.
13. Truong QA, Cannon CP, Zakai NA, et al. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. Am Heart J 157: 673-679, 2009.
14. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 40: 298-303, 2002.
15. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44: 1393-1399, 2004.
16. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29: 2909-2945, 2008.
17. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarc-tion and renal dysfunction: a high-risk combination. Ann Intern Med 137: 563-570, 2002.
18. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52: 599-604, 2008.
19. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93: C29-C34, 2003.
20. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimensin 1620 patients undergoing coronary angioplasty. Arch Intern Med 162: 329-336, 2002.
21. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 354: 379-386, 2006.
22. Nikolsky E, Mehran R, Lasic Z, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67: 706-713, 2005.
23. McCullough PA, Adam A, Becker CR, et al; CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98: 5K-13K, 2006.
24. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004.
25. Yamaguchi J, Kasanuki H, Ishii Y, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 93: 1526-1528, 2004.
26. Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. J Am Coll Cardiol JACC Cardiovasc Interv 5: 90-97, 2012.
27. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113: 1799-1806, 2006.
28. Tziakas D, Chalikias G, Stakos D, et al. Development of an easily applicable risk score model for contrast-induced Nephropathy prediction after percutaneous coronary intervention A novel approach tailored to current practice. Int J Cardiol 163: 46-55, 2013.
29. McCullough PA, Manley HJ. Prediction and prevention of contrast nephropathy. J Interv Cardiol 14: 547-558, 2001.
30. Sgura FA, Bertelli L, Monopoli D, et al. Mehran contrast-induced nephropathy risk score predicts short-and long-term clinical outcomes in patients with ST-elevation myocardial linfarction. Circ Cardiovasc Interv 3: 491-498, 2010.